Omalizumab Retreatment of Patients swith Chronic Idopathic Urticaria/Spontaneous Urticaria (CIU/CSU) Following Return of Symptoms: Primary Results of the OPTIMA Study. J of Skin [Internet]. 2017 Oct. 27 [cited 2025 Apr. 19];1(3.1):s127. Available from: https://skin.dermsquared.com/skin/article/view/183